Drug maker YSP queried over sharp rise in share price


Steady prospects: At YSP research and development centre. The company is expected to gain from increasing domestic consumption as well as in exports.

PETALING JAYA: Under-the-radar drug manufacturer YSP Southeast Asia Holdings Bhd was issued with an unusual market activity query last Friday by the stock-exchange regulator.

The company’s share price has jumped 113.66% since mid-May to close at RM3.44 on Friday, a performance in contrast to the wider market, which has been bearish.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

FBM KLCI stays firm, but profit-taking pressures mount
Trading ideas: Sime Plantation, Sapura Energy, Power Root, OCK, Pekat, Yinson, Mobilia, Siab, Ireka
Loan growth of 7% for CIMB
Awantec to bank on synergistic offerings
Dayang on course for strong performance this year
KLK takes swift action to address labour report
Semiconductor industry offers chance for growth
Tasco’s diversity provides strong growth prospects
FBM KLCI’s bullish momentum
OCK in Laos tower leasing agreement

Others Also Read